Literature DB >> 22142474

New antimalarial indolone-N-oxides, generating radical species, destabilize the host cell membrane at early stages of Plasmodium falciparum growth: role of band 3 tyrosine phosphorylation.

Antonella Pantaleo1, Emanuela Ferru, Rosa Vono, Giuliana Giribaldi, Omar Lobina, Françoise Nepveu, Hany Ibrahim, Jean-Pierre Nallet, Franco Carta, Franca Mannu, Proto Pippia, Estela Campanella, Philip S Low, Francesco Turrini.   

Abstract

Although indolone-N-oxide (INODs) genereting long-lived radicals possess antiplasmodial activity in the low-nanomolar range, little is known about their mechanism of action. To explore the molecular basis of INOD activity, we screened for changes in INOD-treated malaria-infected erythrocytes (Pf-RBCs) using a proteomics approach. At early parasite maturation stages, treatment with INODs at their IC(50) concentrations induced a marked tyrosine phosphorylation of the erythrocyte membrane protein band 3, whereas no effect was observed in control RBCs. After INOD treatment of Pf-RBCs we also observed: (i) accelerated formation of membrane aggregates containing hyperphosphorylated band 3, Syk kinase, and denatured hemoglobin; (ii) dose-dependent release of microvesicles containing the membrane aggregates; (iii) reduction in band 3 phosphorylation, Pf-RBC vesiculation, and antimalarial effect of INODs upon addition of Syk kinase inhibitors; and (iv) correlation between the IC(50) and the INOD concentrations required to induce band 3 phosphorylation and vesiculation. Together with previous data demonstrating that tyrosine phosphorylation of oxidized band 3 promotes its dissociation from the cytoskeleton, these results suggest that INODs cause a profound destabilization of the Pf-RBC membrane through a mechanism apparently triggered by the activation of a redox signaling pathway rather than direct oxidative damage.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142474      PMCID: PMC3385926          DOI: 10.1016/j.freeradbiomed.2011.11.008

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  53 in total

1.  Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites.

Authors:  A M Brunati; L Bordin; G Clari; P James; M Quadroni; E Baritono; L A Pinna; A Donella-Deana
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

2.  Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes.

Authors:  G Giribaldi; D Ulliers; F Mannu; P Arese; F Turrini
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

Review 3.  Hereditary elliptocytosis: spectrin and protein 4.1R.

Authors:  Patrick G Gallagher
Journal:  Semin Hematol       Date:  2004-04       Impact factor: 3.851

Review 4.  Mechanisms of band 3 oxidation and clustering in the phagocytosis of Plasmodium falciparum-infected erythrocytes.

Authors:  Franco Turrini; Giuliana Giribaldi; Franco Carta; Franca Mannu; Paolo Arese
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

5.  Redox metabolism in malaria: from genes, through biochemistry and pathology, to drugs.

Authors:  Hagai Ginsburg
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

6.  Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.

Authors:  Rachida Tahar; Livia Vivas; Leonardo Basco; Eloise Thompson; Hany Ibrahim; Jérémie Boyer; Françoise Nepveu
Journal:  J Antimicrob Chemother       Date:  2011-08-22       Impact factor: 5.790

Review 7.  [Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents].

Authors:  Henri Wajcman; Frédéric Galactéros
Journal:  C R Biol       Date:  2004-08       Impact factor: 1.583

8.  In vitro Plasmodium falciparum drug sensitivity assay: inhibition of parasite growth by incorporation of stomatocytogenic amphiphiles into the erythrocyte membrane.

Authors:  Hanne L Ziegler; Dan Staerk; Jette Christensen; Lars Hviid; Henry Hägerstrand; Jerzy W Jaroszewski
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

9.  Accelerated senescence of human erythrocytes cultured with Plasmodium falciparum.

Authors:  Fausta Omodeo-Salè; Anna Motti; Nicoletta Basilico; Silvia Parapini; Piero Olliaro; Donatella Taramelli
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

Review 10.  Oxidative stress and rheology in severe malaria.

Authors:  A M Dondorp; F Omodeo-Salè; K Chotivanich; D Taramelli; N J White
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

View more
  14 in total

Review 1.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

2.  A spiral scaffold underlies cytoadherent knobs in Plasmodium falciparum-infected erythrocytes.

Authors:  Jean M Watermeyer; Victoria L Hale; Fiona Hackett; Daniel K Clare; Erin E Cutts; Ioannis Vakonakis; Roland A Fleck; Michael J Blackman; Helen R Saibil
Journal:  Blood       Date:  2015-12-04       Impact factor: 22.113

Review 3.  1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.

Authors:  Didier Belorgey; Don Antoine Lanfranchi; Elisabeth Davioud-Charvet
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 4.  Advances in Development of New Treatment for Leishmaniasis.

Authors:  Juliana Perrone Bezerra de Menezes; Carlos Eduardo Sampaio Guedes; Antônio Luis de Oliveira Almeida Petersen; Deborah Bittencourt Mothé Fraga; Patrícia Sampaio Tavares Veras
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

Review 5.  Oxidative stress and β-thalassemic erythroid cells behind the molecular defect.

Authors:  Lucia De Franceschi; Mariarita Bertoldi; Alessandro Matte; Sara Santos Franco; Antonella Pantaleo; Emanuela Ferru; Franco Turrini
Journal:  Oxid Med Cell Longev       Date:  2013-09-24       Impact factor: 6.543

6.  Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia.

Authors:  Kristina R Kesely; Antonella Pantaleo; Francesco M Turrini; Peter Olupot-Olupot; Philip S Low
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

7.  Syk inhibitors interfere with erythrocyte membrane modification during P falciparum growth and suppress parasite egress.

Authors:  Antonella Pantaleo; Kristina R Kesely; Maria Carmina Pau; Ioannis Tsamesidis; Evelin Schwarzer; Oleksii A Skorokhod; Huynh D Chien; Marta Ponzi; Lucia Bertuccini; Philip S Low; Francesco M Turrini
Journal:  Blood       Date:  2017-06-20       Impact factor: 22.113

8.  The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.

Authors:  Katharina Ehrhardt; Christiane Deregnaucourt; Alice-Anne Goetz; Tzvetomira Tzanova; Valentina Gallo; Paolo Arese; Bruno Pradines; Sophie H Adjalley; Denyse Bagrel; Stephanie Blandin; Michael Lanzer; Elisabeth Davioud-Charvet
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

Review 9.  The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?

Authors:  Patrick M Lelliott; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  Malar J       Date:  2015-07-29       Impact factor: 2.979

10.  Band 3 Erythrocyte Membrane Protein Acts as Redox Stress Sensor Leading to Its Phosphorylation by p (72) Syk.

Authors:  Antonella Pantaleo; Emanuela Ferru; Maria Carmina Pau; Amina Khadjavi; Giorgia Mandili; Alessandro Mattè; Alessandra Spano; Lucia De Franceschi; Proto Pippia; Francesco Turrini
Journal:  Oxid Med Cell Longev       Date:  2015-12-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.